Our Pricing

What Is Wegovy Used For? Complete UK Clinical Guide

Understanding what is Wegovy used for is essential before starting treatment — this prescription-only medicine contains semaglutide and is licensed by the MHRA specifically for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidaemia. At Cured Pharmacy, we provide genuine Novo Nordisk Wegovy from £69.00, following a comprehensive clinical assessment by our UK-registered prescribers to ensure suitability and safety for every patient.

What Is Wegovy Used For? Primary Medical Indications

What is Wegovy used for in clinical practice? Wegovy (semaglutide 2.4mg) is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial BMI of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related comorbid condition [1]. This GLP-1 receptor agonist works by mimicking the naturally occurring hormone glucagon-like peptide-1, which regulates appetite and food intake through central nervous system pathways.

The STEP clinical trial programme demonstrated that Wegovy, when used as prescribed alongside lifestyle modifications, resulted in an average weight reduction of 15-17% from baseline over 68 weeks in participants without diabetes [1]. Importantly, Wegovy is not approved for type 2 diabetes management at the 2.4mg dose — patients requiring glycaemic control should discuss alternative semaglutide formulations with their prescriber. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every Wegovy prescription dispensed from Cured Pharmacy meets strict MHRA licensing criteria and patient-specific clinical requirements.

Approved Weight-Related Comorbidities for Wegovy Use

When determining what is Wegovy used for in overweight patients (BMI 27-29.9 kg/m²), the presence of specific weight-related health conditions is mandatory for prescription eligibility. Approved comorbidities include type 2 diabetes mellitus, hypertension (high blood pressure), dyslipidaemia (abnormal cholesterol or triglyceride levels), obstructive sleep apnoea, or cardiovascular disease [2]. These conditions significantly increase health risks, and clinical evidence shows that even modest weight reduction of 5-10% can improve metabolic parameters and reduce cardiovascular risk factors in this patient population.

How Wegovy Works: Understanding What Wegovy Is Used For Mechanistically

To fully grasp what is Wegovy used for, it's essential to understand its mechanism of action. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1 [3]. When administered subcutaneously once weekly, Wegovy activates GLP-1 receptors in the brain's appetite regulation centres, particularly the hypothalamus and brainstem, leading to reduced hunger, increased satiety, and decreased food cravings.

Additionally, Wegovy slows gastric emptying, which prolongs the feeling of fullness after meals and reduces overall caloric intake throughout the day [3]. Unlike stimulant-based weight loss medications, Wegovy does not increase heart rate or blood pressure — in fact, clinical trials have shown modest reductions in systolic blood pressure among users. This physiological approach to appetite regulation explains what is Wegovy used for beyond simple calorie restriction: it addresses the biological drivers of obesity by modulating hormonal signals that control eating behaviour.

What Is Wegovy Used For? Dosing Schedule and Treatment Duration

Understanding what is Wegovy used for includes knowing the proper dosing escalation protocol designed to minimise gastrointestinal side effects. Treatment begins with 0.25mg once weekly for four weeks, followed by monthly increases through 0.5mg, 1mg, and 1.7mg, ultimately reaching the maintenance dose of 2.4mg by week 17 [2]. This gradual titration allows the body to adapt to semaglutide's effects on gastric motility and appetite regulation.

Wegovy is intended for long-term chronic weight management — it is not a short-term solution. Clinical trials extending beyond one year have demonstrated sustained weight loss and metabolic improvements when treatment continues alongside lifestyle modifications [1]. Patients should inject Wegovy subcutaneously in the abdomen, thigh, or upper arm on the same day each week, with or without meals. If a dose is missed by more than five days, patients should resume at the next scheduled dose rather than doubling up, which could increase side effect risk.

Treatment Response and Continuation Criteria

When evaluating what is Wegovy used for in individual patients, prescribers assess treatment response at 16-20 weeks after reaching the maintenance dose. NICE guidance suggests that if a patient has not achieved at least 5% weight loss from baseline by this point, continuation of Wegovy may not be clinically appropriate [2]. However, many patients achieve significantly greater weight reduction — in STEP 1, 50% of participants lost 15% or more of their body weight over 68 weeks. Regular monitoring by healthcare professionals ensures Wegovy continues to deliver meaningful clinical benefit for each individual.

What Is Wegovy Used For? Comparing Weight Loss Treatment Options UK

When considering what is Wegovy used for relative to other UK-licensed weight management treatments, several pharmacological options exist with distinct mechanisms and efficacy profiles. Wegovy (semaglutide) and Mounjaro (tirzepatide) are both injectable GLP-1 receptor agonists, though tirzepatide also activates GIP receptors, potentially offering enhanced weight loss in head-to-head trials [4]. Saxenda (liraglutide) is an earlier-generation GLP-1 agonist requiring daily injections rather than weekly administration.

Oral medications like orlistat (available as Xenical, Alli, or generic formulations) work through a completely different mechanism — blocking dietary fat absorption in the intestine rather than modulating appetite hormones. Mysimba combines naltrexone and bupropion to reduce cravings through central nervous system pathways. The choice between these treatments depends on individual medical history, BMI, comorbidities, injection tolerance, and prescriber assessment. At Cured Pharmacy, our clinical team evaluates each patient's unique circumstances during the online consultation to recommend the most appropriate weight management option, with Wegovy priced from £69.00 for genuine Novo Nordisk supply.

What Is Wegovy Used For? Side Effects and Safety Considerations

Understanding what is Wegovy used for includes awareness of potential adverse effects, predominantly gastrointestinal in nature. The most commonly reported side effects include nausea (affecting up to 44% of users), diarrhoea, vomiting, constipation, abdominal pain, and dyspepsia [1]. These effects are typically mild to moderate, occur most frequently during dose escalation, and diminish over time as the body adapts to treatment.

More serious but rare risks include pancreatitis, gallbladder disease, hypoglycaemia (particularly in patients taking concomitant diabetes medications), acute kidney injury secondary to dehydration, and allergic reactions [2]. Wegovy carries a boxed warning in some jurisdictions regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use Wegovy. Our prescribers at Cured Pharmacy conduct thorough medical history reviews to identify contraindications before approving any Wegovy prescription.

Who Should Not Use Wegovy?

When determining what is Wegovy used for, it's equally important to understand who should avoid this treatment. Absolute contraindications include personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, pregnancy or breastfeeding, and known hypersensitivity to semaglutide or any excipients [2]. Wegovy should be used with caution in patients with a history of pancreatitis, severe gastrointestinal disease, diabetic retinopathy, or renal impairment. Patients under 18 years of age have not been studied in clinical trials for the 2.4mg dose. All prescription decisions at Cured Pharmacy are made by UK-registered prescribers following comprehensive clinical assessment to ensure patient safety and treatment appropriateness.

What Is Wegovy Used For? Accessing Treatment Through Cured Pharmacy UK

Now that you understand what is Wegovy used for clinically, accessing this prescription treatment through Cured Pharmacy is straightforward and fully compliant with UK regulations. Our GPhC-registered online pharmacy (9012511) requires all patients to complete a comprehensive medical questionnaire reviewed by our UK-registered prescribers. This typically takes under three minutes and covers your medical history, current medications, weight management goals, and any contraindications.

If approved, genuine Novo Nordisk Wegovy is dispensed from our UK pharmacy and delivered discreetly to your address with next-day delivery options available. Wegovy is priced from £69.00 at Cured Pharmacy, with an additional £20 off your first order using code Weightlossnew — representing the cheapest UK price for this licensed weight management treatment. We guarantee 100% genuine UK-licensed medicines, transparent upfront pricing shown before consultation, and ongoing support from our clinical team led by superintendent pharmacist Tarun Kumar. Understanding what is Wegovy used for is the first step — accessing safe, affordable treatment through a trusted UK pharmacy is the next.

Ongoing Monitoring and Prescription Renewals

Successful long-term weight management with Wegovy requires regular clinical monitoring to assess treatment response, tolerability, and continued appropriateness. At Cured Pharmacy, prescription renewals involve follow-up consultations where our prescribers review your weight loss progress, any side effects experienced, and overall health status. This ensures what is Wegovy used for in your individual case continues to align with clinical best practice and MHRA licensing criteria. Patients are encouraged to maintain regular contact with their NHS GP for comprehensive health monitoring, including blood pressure, lipid profiles, and glycaemic control where applicable.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
2. Novo Nordisk. (2023). Wegovy (semaglutide) Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency (MHRA). [accessed 15 August 2026]
3. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. [accessed 15 August 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.